It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
BACKGROUND: Catecholamines are recommended as first-line drugs to treat hemodynamic instability
after out-of-hospital cardiac arrest (OHCA). The benefit-to-risk ratio of catecholamines is dose dependent,
however, their effect on metabolism and organ function early after OHCA has not been investigated.
METHODS: The Post-Cardiac Arrest Syndrome (PCAS) pilot study was a prospective, observational,
multicenter study. The primary outcomes of this analysis were association between norepinephrine/
/cumulative catecholamines doses and neuron specific enolase (NSE)/lactate concentration over the first
72 hours after resuscitation. The association was adjusted for proven OHCA mortality predictors and
verified with propensity score matching (PSM).
RESULTS: Overall 148 consecutive OHCA patients; aged 18–91 (62.9 ± 15.27), 41 (27.7%) being female,
were included. Increasing norepinephrine and cumulative catecholamines doses were significantly associated
with higher NSE concentration on admission (r = 0.477, p < 0.001; r = 0.418, p < 0.001) and
at 24 hours after OHCA (r = 0.339, p < 0.01; r = 0.441, p < 0.001) as well as with higher lactate concentration
on admission (r = 0.404, p < 0.001; r = 0.280, p < 0.01), at 24 hours (r = 0.476, p < 0.00;
r = 0.487, p < 0.001) and 48 hours (r = 0.433, p < 0.01; r = 0.318, p = 0.01) after OHCA. The associations
remained significant up to 48 hours in non-survivors after PSM.
CONCLUSIONS: Increasing dose of catecholamines is associated with higher lactate and NSE concentration,
which may suggest their importance for tissue oxygen delivery, anaerobic metabolism, and organ
function early after OHCA.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Wood, Alice 2 ; Bohm, Allan 3 ; Kwasiborski, Przemysław 4 ; Oleksiak, Anna 5 ; Ryczek, Robert 6 ; Grand, Johannes 7 ; Tavazzi, Guido 8 ; Sionis, Alessandro 9 ; Stępińska, Janina 5 1 Division of Cardiology, Andrzej Frycz Modrzewski Krakow University, Krakow, Poland. [email protected]
2 University Hospitals of Leicester, United Kingdom
3 Department of Acute Cardiology, National Institute of Cardiovascular Diseases, Bratislava, Slovakia
4 Third Department of Internal Diseases and Cardiology, Warsaw Medical University, Warsaw, Poland
5 Department of Intensive Cardiac Therapy, National Institute of Cardiology, Warsaw, Poland
6 Department of Cardiology, Military Institute of Medicine, Warsaw, Poland
7 Department of Cardiology, University Hospital of Copenhagen, Denmark
8 Department of Clinical Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Italy
9 Intensive Cardiac Care Unit Cardiology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain





